GlaxoSmithKline S.A.E. (BIOC.CA)

Also known as:  GSK Egypt, GlaxoSmithKline Egypt
Data delayed by 15 minutes
16.02 EGP -1.77-9.949%
As of 16 JAN 2020 09:06 GMT|Egypt SE

GSK Egypt Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
2.53%
P/E (Last 12 Month)
40.859
Upside
-
Target Price (Mean)
-
52Wk
17.79 15 JAN
17.79 15 JAN

Open
16.02 EGP
Previous Close
17.79 EGP
Turnover
47.42K EGP
EPS
-
Volume
2,960
Transactions
4
Market Cap
1.49B EGP
IPO Date
01-Sep-1993
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About GlaxoSmithKline S.A.E.Last updated on: 15 January 2018

Business Summary
Manufacture of branded and generic drugs, chemicals, veterinary, vitamins and nutritional products, pharmaceutical and bulk drugs substance.
Country of Incorporation
Ownership Type
Established In
1981
Primary Sector
Number of Employees
1000
Stock Listing
IDStock TypeCurrencyExchangeSymbol
BIOC.CASEOrdinaryEGPEgypt SEBIOC

Contact details

Primary address
Boomerang Building 46, Block J
Ninety Street
1st-3rd Floor
5th Settlement
41
Egypt
Cairo
11835
CONTACT
  • Tel: +20 2-2618-5000
  • Fax: +20 2-2618-5001
Region
Cairo
All Related News
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Dr Amro Mohammed Mamdouh Abdulmajid
Managing Director
Dr Ashraf Mohammed Ibrahim Mansour
Medical and Regulatory Director
Mr Amro Abou Naja
Marketing Director

Board Members

Dr Amro Mohammed Mamdouh Abdulmajid
Chairman and director representing GlaxoSmithkline Plc
Dr Ashraf Mohammed Ibrahim Mansour
Director director representing GlaxoSmithkline Plc
Mr Jude Albert Brajanza
Director representing GlaxoSmithkline Plc
All People

Company information provided by © 2020 Thomson Reuters

Thomson Reuters research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
CAIRO PHARMAC.36.000 EGP0.00
EGYPT INTL PHRM65.350 EGP0.00
ALX. PHARMACEUT.102.000 EGP-1.373
MINAPHARM PHARMA84.950 EGP0.00
ARAB PHARM44.000 EGP-1.764
All Peers
Morning Briefing

Thursday Outlook: World stocks pause at record peak as markets assess U.S.-China deal

Thursday Outlook: World stocks pause at record peak as markets assess U.S.-China deal

Dollar softens, gold steadies and oil prices rise  after "phase 1" deal inked

Read More

Most Viewed Stocks

Stock Market Data

Powered By Knowledge Direct

Stock Screener

All Stocks